Proof of principle for epitope-focused vaccine design
Open accessThe DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
Vaccines prevent infectious disease largely by inducing protective neutralizing antibodies against vulnerable epitopes. Several major pathogens have resisted traditional vaccine development, although vulnerable epitopes targeted by neutralizing antibodies have been identified for several such cases. Hence, new vaccine design methods to induce epitope-specific neutralizing antibodies are needed. Here we show, with a neutralization epitope from respiratory syncytial virus, that computational protein design can generate small, thermally and conformationally stable protein scaffolds that accurately mimic the viral epitope structure and induce potent neutralizing antibodies. These scaffolds represent promising leads for the research and development of a human respiratory syncytial virus vaccine needed to protect infants, young children and the elderly. More generally, the results provide proof of principle for epitope-focused and scaffold-based vaccine design, and encourage the evaluation and further development of these strategies for a variety of other vaccine targets, including antigenically highly variable pathogens such as human immunodeficiency virus and influenza.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures














Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Previous methods can scaffold functional sites made up of one or two contiguous chain segments (6–10), but with the exception of helical bundles (8) these do not extend readily to more complex sites composed of three or more chain segments, and the generated backbones are not guaranteed to be designable (encodable by some amino acid sequence).”
From Scaffolding protein functional sites using deep learning (2022) · cites this paper as [7]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Previous methods can scaffold functional sites made up of one or two contiguous chain segments (6–10), but with the exception of helical bundles (8) these do not extend readily to more complex sites composed of three or more chain segments, and the generated backbones are not guaranteed to be designable (encodable by some amino acid sequence).”
From Scaffolding protein functional sites using deep learning (2022) · cites this paper as [7]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Previous methods can scaffold functional sites made up of one or two contiguous chain segments (6–10), but with the exception of helical bundles (8) these do not extend readily to more complex sites composed of three or more chain segments, and the generated backbones are not guaranteed to be designable (encodable by some amino acid sequence).”
From Scaffolding protein functional sites using deep learning (2022) · cites this paper as [7]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
Delaglio, F., Grzesiek, S., Vuister, G., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,965
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
The global distribution and burden of dengue
Bhatt, S., Gething, P. W., Brady, O. J., Messina, J. P., Farlow, A. W., Moyes, C. L., Drake, J. M., Brownstein, J. S., Hoen, A. G., Sankoh, O., et al. (2013) · Nature · doi:10.1038/nature12060 · Cited by 10,037
Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888
NMR View: A computer program for the visualization and analysis of NMR data
Johnson, B. A., & Blevins, R. A. (1994) · Journal of Biomolecular NMR · doi:10.1007/bf00404272 · Cited by 3,090
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908492 · Cited by 3,034
Leaver-Fay (2011) · doi:10.1016/b978-0-12-381270-4.00019-6 · Cited by 1,904
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
Osterholm, M. T., Kelley, N. S., Sommer, A., & Belongia, E. A. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70295-x · Cited by 1,789
Protein Structure Prediction Using Rosetta
Rohl, C. A., Strauss, C. E. M., Misura, K. M. S., & Baker, D. (2004) · Methods in Enzymology · doi:10.1016/s0076-6879(04)83004-0 · Cited by 1,725
Self-citationDesign of a Novel Globular Protein Fold with Atomic-Level Accuracy
Kuhlman, B., Dantas, G., Ireton, G. C., Varani, G., Stoddard, B. L., & Baker, D. (2003) · Science · doi:10.1126/science.1089427 · Cited by 1,670
Self-citation
Research works printed but not linked: 1
- Plotkin SA Orenstein WA Offit PA Vaccines 6 Elsevier 2012
Cited by
Items 501–554 of 554
MODELAGEM DE PROTEÍNAS NO EASYMODELLER
Galúcio, J. M. P. (2022) · doi:10.22533/at.ed.8252228104
Ahmed, M. M. E., Noureen, A., & Rafiq, A. (2023) · Gastroenterology & Hepatology Open Access · doi:10.15406/ghoa.2023.14.00536
De novo design of stable proteins that efficaciously inhibit oncogenic G proteinsPreprint
Cummins, M. C., Tripathy, A., Sondek, J., & Kuhlman, B. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.28.534629
Computational Grafting of Epitopes
Manish, M., Mishra, S., Pahuja, M., Anand, A., Subbarao, N., & Samudrala, R. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3239-0_7
Development of mucoadhesive nanovaccine against columnaris disease in red tilapia (Oreochromis sp.)
Kitiyodom, S. (2019) · Chula Digiverse · doi:10.58837/chula.the.2019.535
Velusamy, S., Abuthakir, M. H. S., Khan, J. M., Ahmad, A., & Jeyam, M. (2023) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2023.102917
Batra, S., Olmo, F., Ragan, T. J., Kaplan, M., Calvaresi, V., Frank, A. M., Lancey, C., Assadipapari, M., Ying, C., Struwe, W. B., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.26.586384
A Comprehensive Review of Tick-Born Blood Protozoan Disease in Cattle: Babesiosis and Vaccination
Khalid, Z. U. R., Rahman, S. U., Munir, M. Z., Jabar, A., & Hussain, I. (2023) · International Journal of Medical Parasitology and Epidemiology Sciences · doi:10.34172/ijmpes.3128
“Such information could also offer priceless insights into how parasites and hosts interact (71-73).”
BackgroundDesign of antigens to present a tumor-specific cryptic epitopePreprint
Xu, H., Palpant, T., Wang, Q., & Shaw, D. E. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.15.588917
“…immunogen composition 33–35 and immunization protocols, 36,37 in order to enhance immunogenicity and focus the antibody response against the epitope, 11 could potentially lead to immunogens that can overcome the obstacles outlined above and robustly elicit mAb806-like, cancer-selective antibodies.”
BackgroundA Unified Framework of Scaffold-Lab for Critical Assessment of Protein Backbone Generation MethodsPreprint
Chen, H., Zheng, Z., Zhang, B., Zhong, B., Liu, K., Li, Z., Zhu, J., Yu, J.-L., & Wei, T. (2024) · Research Square · doi:10.21203/rs.3.rs-4249839/v1
Prevention of fetal and early life infections through maternal-neonatal immunization
Abu-Raya, B., & Edwards, K. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-79525-8.00050-0 · Cited by 1
Protein Manufacture: Protein Design Assisted by Machine Learning from Backbone to Sequence
Xu, M., Luo, Y., Jiang, J., Cui, Z., & Wu, H. (2024) · Lecture notes in computer science · doi:10.1007/978-981-97-5692-6_30
Xu, G., Yang, Y., Zhang, Y., Wang, Q., & Ma, J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.20.608889
“Rational protein design has emerged as a powerful tool in many applications, such as therapeutic engineering (1, 2), binder development (3-5), biosensor construction (6, 7), nanomaterial synthesis (8), and enzyme optimization (9-12).”
BackgroundComputationally designed stem-epitope mimetics elicit broadly reactive antibodiesPreprint
Wehrle, S., Scheck, A., Reusch, L., Matassoli, F. L., Georgeon, S., Castro, K. M., Cramer, J., Harshbarger, W. D., Rosset, S., Andrews, S. F., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.22.634229 · Cited by 2
Self-citationRijal, P., Wei, L., Paesen, G. C., Stuart, D. I., Howarth, M. R., Huang, K.-Y. A., Bowden, T. A., & Townsend, A. (2025) · eLife · doi:10.7554/elife.105317.1
Structure-Guided Vaccine Design
Alam, N., & Higgins, M. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00157-5
Rijal, P., Wei, L., Paesen, G. C., Stuart, D. I., Howarth, M. R., Huang, K.-Y. A., Bowden, T. A., & Townsend, A. (2025) · eLife · doi:10.7554/elife.105317.2
Rational Enzyme Evolution by Facilitating Correlated Motion along the Reaction
Wang, L., Xue, Y., Wang, J., Mo, Y., & Mei, Y. (2025) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5c02133
Reverse and Structural Viral and Bacterial Vaccine Design
Ponnusamy, N., Ravi, N., Palanisamy, T. B., Ahmad, F., & Arumugam, M. (2025) · Springer eBooks · doi:10.1007/978-3-031-77911-4_7
A Review on Conventional and Emerging Methods in Vaccinology: A Case Study on COVID-19
Udayakumar, A., Tripathi, T., & Balaji, S. (2025) · Springer eBooks · doi:10.1007/978-3-031-77911-4_33
Influenza: The search for a universal vaccine
Setliff, I., & Murji, A. A. (2017) · doi:10.64628/aai.yppgn3hjp
Influenza: The search for a universal vaccine
Setliff, I., & Murji, A. A. (2018) · The Conversation · doi:10.64628/aai.hhm59r946
Engineering mucosal immunity: Advanced vaccine platforms against respiratory pathogens
Wang, M., Chang, Q., Li, B., Yang, R., Chen, X., Bai, Y., He, H., & Zheng, B. (2025) · Precision medicine and engineering. · doi:10.1016/j.preme.2025.100040 · Cited by 5
Ahmed, A. U. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.10.018
Deep learning–enabled scaffolding of spatial arrays of PfCSP epitopes
Wu, N. R., Castro, K. M., Beutler, N., Lee, W.-H., Raghavan, S. S. R., Martin, G. M., Jain, M., Agrawal, S., Liguori, A., Kalyuzhniy, O., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2521914123
“This involves a sequence passed to the RoseTTAFold network to predict 3D coordinates that are scored by a motif recapitulation loss function used to then update the sequence to the next iteration of RoseTTAFold (19).”
InfluentialSelf-citationExplore antibody repertoire in the era of AI
Zhang, Y., Wang, H., Liu, C., & Meng, F. (2025) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2025230
Charged scanning mutagenesis as a high‐throughput approach for epitope mapping
Kanjo, K., Bhasin, M., Dey, C., Bakshi, N., Asok, A., Singh, R. K., Kumar, S., Ringe, R. P., & Varadarajan, R. (2025) · Protein Science · doi:10.1002/pro.70433
Jedlitzke, B., Wissett, O., Nguyen, T. H., Ghedin, E., & Sormanni, P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.23.696170
“Similarly, recent progress in structural vaccinology – accurate complex modelling 11,24,25 , escape/antigenic-mapping data 63,64 , and increasingly reliable structural design of immunogens 65–67 – are making epitope-focused strategies increasingly feasible.”
Protein Trimerization and Viral Fusion: Structural Insights and Therapeutic Applications
Mayandi, V., Majumdar, D., Shrestha, P., Kousoulas, K. G., & Jois, S. D. S. (2026) · Challenges and advances in computational chemistry and physics · doi:10.1007/978-3-032-07880-3_8
Dueker, K., Capozzola, T., Feng, Z., Lin, R. N., Hurtado, J., Bangaru, S., Yuan, M., Beutler, N., Garcia, E., He, W.-T., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.22.700386
Geng, B., BangHui, Z., Zhang, Z., Jiang, G., & Zhu, W. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.02878-25
“Epitope-focused vaccine design constitutes an effective technical approach to enhancing the efficacy of genetic engineering vaccines (7).”
Lun, J., Zheng, P., Li, C., Hu, Y., Li, Y., Zhong, M., Zhang, Y., & Hu, Z. (2026) · Journal of Fish Diseases · doi:10.1111/jfd.70167
Self-citationParladé, E., Favaro, M. T. D. P., Chellou-Bakkali, S., Voltà‐Durán, E., López‐Laguna, H., Villaverde, A., & Vázquez, E. (2026) · Biomaterials Advances · doi:10.1016/j.bioadv.2026.214839
Deng, L., Liu, J., & Peng, Y. (2026) · Virologica Sinica · doi:10.1016/j.virs.2026.03.011 · Cited by 1
“…monoclonal antibodies (mAbs) were found targeting epitopes in the pre-F protein, prompting the recognition to prioritize developing pre-F-based vaccine antigens (Mclellan et al., 2013a; Mclellan et al., 2013b; Correia et al., 2014; Mclellan, 2015; Ngwuta et al., 2015; Gilman et al., 2016).”
GeomMotif: A Benchmark for Arbitrary Geometric Preservation in Protein GenerationPreprint
Strashnov, P., Shevtsov, A., Meshchaninov, V., Kardymon, O. L., & Vetrov, D. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.18.719378 · Cited by 3
“Subsequent developments included RosettaDesign (Kuhlman et al., 2003), enzyme design modules (Richter et al., 2011), and the fold-from-loops approach for epitope grafting (Correia et al., 2014).”
Clark, N. M., Keles, N. K., Hagedorn, G. N., Klenchin, V. A., Andersen, H., Treece, J., Fennessey, C. M., Xie, J., Denny, T. N., DeMarco, C. T., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.20.719478
“01 ( 12, 14 ) and the RSV F-specific control antibody 17-HD9 ( 13 ) were cloned into the AAV transfer plasmid downstream of a CMV enhancer, chicken b -actin promotor and an SV40 intron and upstream of a WPRE and SV40 polyadenylation site.”
Shaping the Future of Vaccine Design: A Historical Perspective on Rational Vaccine Thinking
Kieber‐Emmons, T. (2026) · Pharmaceutical science. · doi:10.5772/intechopen.1015569
Structures of New World mammarenavirus glycoproteins as targets for antibody-mediated neutralization
Taylor, L. J., Helguera, G. F., Maruyama, J., & Rodríguez, J. A. (2026) · Journal of Virology · doi:10.1128/jvi.01626-25 · Cited by 1
“Structures could directly inform on target epitopes (32) and prefusion-stabilized GPC states (30) and open the door to machine learning-assisted immunogen or antibody design, as has been demonstrated for other challenging vaccine targets (56, 57).”
Quintero-Barbosa, J. S., Song, Y., Mehl, F., Mathur, S., Livingston, L., Shen, X., Montefiori, D. C., & Zeichner, S. L. (2026) · Viruses · doi:10.3390/v18080890
“…together with the inherent danger signal provided by a particulate immunogen [64], PADRE-mediated T-cell help, and high local peptide density [65], could support stronger B-cell activation, germinal center entry [66], affinity maturation [67], with development of the desired antibody response.”
Coluzza, I. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-99507-8.00090-1
De Novo Synthesis in Cancer Immunotherapy: Applications and Prospects
Yang, J., Wu, Y., & Luo, J. (2026) · MedComm · doi:10.1002/mco2.70847
Intelligent antigen design combined with yeast display enhances targeted immune responses
Ma, Y.-F., Yin, G.-H., Pan, Y. L., & Liu, Y. (2026) · Briefings in Bioinformatics · doi:10.1093/bib/bbag393
“These epitopes can be grafted onto natural protein scaffolds or reconstructed using de novo scaffolds [ 17– 19].”
Kumar, R., Muthuramalingam, P., Tiwari, S., Gupta, J., Gupta, R., Agarwal, P., Yadav, H., Kumar, N., Rawat, J. M., Ravi, K., et al. (2026) · Computational and Structural Biotechnology Journal · doi:10.34133/csbj.0199
“Because cavity-filling mutations are often introduced outside major antigenic sites, they may preserve epitope presentation; however, the effects on anti-genicity remain context dependent and require experimental validation [ 6 , 29 ].”
Structured peptides as vaccine antigens against infections
Trappetti, C., van Ingen, H., Falconi, M., Romeo, A., Sancamillo, G., Caprini, M., Oggioni, M. R., & Sette, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1908831
Mimotope-Guided Molecular Dynamics Enables Precise Functional Epitope Mapping
Sha, Z., Hu, Z., Du, W., Martí, J., Sundell, G. N., Guo, S.-J., Zhao, X., & Tao, S. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6c01562
Advances in de novo protein design for anti-infective applications
Yin, J., 顾子春, Sun, Y., & Tao, L. (2026) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/csb-2026-0714
Garba, A., Usman, S., & Hussaini, A. (2026) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2026.111213
Structural biology approaches in vaccine development
Taiyab, A., & Hassan, I. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44988-8.00011-3
MIMOSA: Guiding De Novo Antibody Design with Natural Interaction FingerprintsPreprint
Abanades, B., Roncoli, A., Bhagawati, M., Kessel, P., Imhof-Jung, S., Doerr, D., Schilz, J., Vasilaki, S., Seeger, F., Bonvin, A. M. J. J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.24.753155
“Unlike conventional motif scaffolding (Azoitei et al., 2011; Correia et al., 2014; Watson et al., 2023; Lin et al., 2026), the mimic potential does not require a pre-determined mapping between motif residues and output sequence positions.”
Antigen prioritization and selection for vaccine design and development: A comprehensive pipeline
Chelan, E. M., Pourseif, M. M., Zarebkohan, A., Moghaddam, H. G., Kiani, J., Tohidkia, M., Almasian, B., Parhizkar, A., & Omidi, Y. (2026) · Biotechnology Advances · doi:10.1016/j.biotechadv.2026.109063
Banisaeed, S. R., Rasooli, I., Ghazanfari, T., Ajdary, S., & Nikbin, V. S. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.129205
Solving the Staphylococcus aureus puzzle: lessons to guide future MRSA vaccine development
Mills, E., Borgo, M. P. D., & O’Keeffe, M. A. (2026) · Clinical Microbiology Reviews · doi:10.1128/cmr.00112-26
“Epitope vaccines are able to induce highly specific responses without the induction of immunity against epitopes not covered by the vaccine, thus limiting the contribution of unhelpful established memory responses (331).”
Maternal Immunization: Optimizing Passive Immunity in the Newborn
Michie, C. A. (2026) · Newborn · doi:10.5005/jp-journals-11002-0173 · Cited by 1
Metadata
- Authors
- Correia, B. E., Bates, J. T., Loomis, R. J., Baneyx, G., Carrico, C., Jardine, J. G., Rupert, P., Correnti, C., Kalyuzhniy, O., Vittal, V., Connell, M. J., Stevens, E., Schroeter, A., Chen, M., MacPherson, S., Serra, A. M., Adachi, Y., Holmes, M. A., Li, Y., Klevit, R. E., Graham, B. S., Wyatt, R. T., Baker, D., Strong, R. K., Crowe, J. E., Johnson, P. R., & Schief, W. R.
- Affiliations
- Scripps Research Institute (US)
- Vanderbilt University Medical Center (US)
- Children's Hospital of Philadelphia (US)
- University of Washington (US)
- Fred Hutch Cancer Center (US)
- National Institutes of Health (US)
- Corresponding author
- Schief, William R.
- ORCID
- Venue
- Nature
- Published
- 2014-02-05
- Volume
- 507
- Issue
- 7491
- Pages
- 201-206
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4260937
- OpenAlex
- W2040299410
- Cited by
- 555
- References
- 38
- Citations by year
- 2026: 39 · 2025: 40 · 2024: 37 · 2023: 32 · 2022: 55 · 2021: 44 · 2020: 43 · 2019: 45 · 2018: 40 · 2017: 47 · 2016: 50 · 2015: 52 · 2014: 30
- FWCI
- 24.45
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion, cc-by-nc)
- PubMed Central (acceptedVersion, cc-by-nc)
- Funders
- Bill and Melinda Gates Foundation
- International AIDS Vaccine Initiative
- March of Dimes Foundation
- Children's Hospital of Philadelphia
- University of Washington
- National Institutes of Health
- Center for AIDS Research, University of Washington
- University of California, San Diego
- National Cancer Institute (T32CA080416)
- National Institute of General Medical Sciences (T32GM007270)
- National Institute of Allergy and Infectious Diseases (P30AI 36214, U54AI057141, U54 AI 005714, R01AI102766, UM1AI100663, R21AI088554, P01AI094419, P30AI036214, P30AI045008)
- Center for AIDS Research, University of California, San Diego
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- RSV vaccine, neutralizing antibodies, computational protein design, protein scaffolds, antigenic determinants, vaccine development
- MeSH terms
- Animals, Antibodies, Monoclonal, Antibodies, Viral, Epitopes, Antigens, Viral, Enzyme-Linked Immunosorbent Assay, Macaca mulatta, Male, Mice, Inbred BALB C, Models, Molecular, Neutralization Tests, Protein Conformation, Respiratory Syncytial Viruses, Drug Design, Crystallography, X-Ray, Amino Acid Motifs, Respiratory Syncytial Virus Vaccines, Mice, Protein Stability, Antibodies, Neutralizing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.